“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm

L Cox, T Piatkowski, J McVeigh - Drugs: Education, Prevention and …, 2024 - Taylor & Francis
Background This investigation explores the concept of stigma related to people who use
anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic …

Support for people who use Anabolic Androgenic Steroids: A Systematic Sco** Review into what they want and what they access

O Harvey, S Keen, M Parrish, E van Teijlingen - BMC Public Health, 2019 - Springer
Background Since there is a paucity of research on support for people using Anabolic
Androgenic Steroids (AAS), we aimed to identify and synthesise the available evidence in …

Exploring the experiences of general practitioners working with patients who use performance and image enhancing drugs

M Dunn, T Piatkowski, B Whiteside, B Eu - Performance Enhancement & …, 2023 - Elsevier
Objective Medical practitioners such as general practitioners (GPs) may have an
underutilized role when it comes to addressing the associated harms among people who …

The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study

O Corazza, P Simonato, Z Demetrovics, R Mooney… - PloS one, 2019 - journals.plos.org
Introduction In a society that perpetuates the strive for a perfect appearance, a fit body has
become synonymous with success, but simultaneously hard to achieve. This represents a …

[HTML][HTML] Big business: The private sector market for image and performance enhancing drug harm reduction in the UK

L Turnock, N Gibbs, L Cox, T Piatkowski - International Journal of Drug …, 2023 - Elsevier
This article draws on three mutually independent ethnographic studies to explore the private
sector market for image and performance enhancing drug (IPED) harm reduction in the UK …

Characteristics and attitudes of men using anabolic androgenic steroids (AAS): a survey of 2385 men

AK Bonnecaze, T O'Connor… - American journal of …, 2020 - journals.sagepub.com
Additional characterization of patients using anabolic androgenic steroids (AAS) is needed
to improve harm reduction and cessation resources for patients. Our group sought to expand …

Navigating risks and reducing harm: a gendered analysis of anabolic–androgenic steroid users within the risk environment framework

T Piatkowski, M Dunn - Contemporary Drug Problems, 2024 - journals.sagepub.com
Introduction: The existing body of literature on harm reduction for those who use anabolic–
androgenic steroids (AASs) predominantly concentrates on men, thereby neglecting the …

[HTML][HTML] Anabolic-androgenic steroid use among women–A qualitative study on experiences of masculinizing, gonadal and sexual effects

IA Havnes, ML Jørstad, I Innerdal… - International Journal of …, 2021 - Elsevier
Background Female users of anabolic-androgenic steroids (AAS) are at risk of develo**
masculinizing side effects. This study explores how the development of masculinizing effects …

'The general concept is a safer use approach': how image and performance enhancing drug coaches negotiate safety through community care

T Piatkowski, L Cox, N Gibbs, L Turnock… - … , Prevention and Policy, 2024 - Taylor & Francis
Background Drug coaches are a novel extension of traditional personal trainers who play a
significant role providing support and sha** drug-related behaviours for people who use …

Gendered perspectives on women's anabolic–androgenic steroid (AAS) usage practices

T Piatkowski, J Robertson, S Lamon, M Dunn - Harm Reduction Journal, 2023 - Springer
Background The masculinizing effects from anabolic–androgenic steroid (AAS) appear to be
different between men and women, leading to calls for more gender-specific information …